Terms: = Colorectal cancer AND POU2AF1, OBF1, 5450, ENSG00000110777, BOB1, OCAB, Q16633, OBF-1
4 results:
1. Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials.
Abdel-Rahman O; Karachiwala H
Int J Colorectal Dis; 2019 Oct; 34(10):1741-1747. PubMed ID: 31492988
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.
You J; Liu WY; Zhu GQ; Wang OC; Ma RM; Huang GQ; Shi KQ; Guo GL; Braddock M; Zheng MH
Oncotarget; 2015 Aug; 6(23):19880-90. PubMed ID: 26082438
[TBL] [Abstract] [Full Text] [Related]
3. Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer.
Pittman AM; Webb E; Carvajal-Carmona L; Howarth K; Di Bernardo MC; Broderick P; Spain S; Walther A; Price A; Sullivan K; Twiss P; Fielding S; Rowan A; Jaeger E; Vijayakrishnan J; Chandler I; Penegar S; Qureshi M; Lubbe S; Domingo E; Kemp Z; Barclay E; Wood W; Martin L; Gorman M; Thomas H; Peto J; Bishop T; Gray R; Maher ER; Lucassen A; Kerr D; Evans GR; ; van Wezel T; Morreau H; Wijnen JT; Hopper JL; Southey MC; Giles GG; Severi G; Castellví-Bel S; Ruiz-Ponte C; Carracedo A; Castells A; ; Försti A; Hemminki K; Vodicka P; Naccarati A; Lipton L; Ho JW; Cheng KK; Sham PC; Luk J; Agúndez JA; Ladero JM; de la Hoya M; Caldés T; Niittymäki I; Tuupanen S; Karhu A; Aaltonen LA; Cazier JB; Tomlinson IP; Houlston RS
Hum Mol Genet; 2008 Dec; 17(23):3720-7. PubMed ID: 18753146
[TBL] [Abstract] [Full Text] [Related]
4. Syndrome of primary multiple endometrial, breast, ovarian and colon adenocarcinoma.
Maximov SJ; Bokhman JB
Eur J Gynaecol Oncol; 1993; 14(2):109-13. PubMed ID: 8500491
[TBL] [Abstract] [Full Text] [Related]
